研究进展和纳米材料用于抑郁症治疗的未来前景:科学测量综述
Dong Xu1, Chao Guo2, Wang-Ting Li2
1Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, 127 Changle West Street, Xi'an, 710032, China. dongxu418@163.com.
Journal of nanobiotechnology
|February 27, 2026
概括
这项研究回顾了用于抑郁症治疗的纳米材料,强调了它们的诊断和治疗潜力. 研究显示,对纳米药物输送系统和抗抑郁药物纳米材料的兴趣日益增加,中国,印度和伊朗在出版物方面处于领先地位.
科学领域:
- *纳米材料研究涵盖材料科学,纳米技术和药学/化学.
- *重点领域包括诊断,抗抑郁药纳米材料,纳米药物输送和纳米毒性.
背景情况:
- * 抑郁症严重影响身体和心理健康.
- *纳米材料越来越多地被用于抑郁症诊断和治疗.
研究的目的:
- * 客观地总结抑郁症治疗纳米材料的研究进展.
- * 探索这个领域的未来前景和科学度分析.
主要方法:
- * 在 Web of Science,Scopus 和 PubMed 进行文献搜索.
- *使用Bibliometrix进行科学度分析,包括出版趋势,关键词和合作.
- * 基于分析的数据进行讨论,以提出潜在的应用.
主要成果:
- *发表了343篇文章,出版量每年都在增加.
- *中国,印度和伊朗是领先的国家;确定了关键机构和期刊.
- *关键词表明重点是诊断,抗抑郁药活性,纳米药物输送和纳米毒性.
结论:
- * 科学度分析提供了关于诊断,治疗和限制的见解.
- *强调纳米材料在抑郁症治疗中的潜力.
- *旨在激发该领域纳米材料开发的新思路.
相关概念视频
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.5K
Depressive Disorders: Etiology
793
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
793
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Antidepressant Drugs: Overview
1.8K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.8K


